| Completed | 2 | 450 | RoW | Benznidazole, P01CA02, Abarax, Radanil, Rochagan, Nifurtimox, Lampit, P01CC01, QP51AC01 | University of Texas, El Paso, Fundación Ciencia y Estudios Aplicados para el Desarrollo en Salud y Medio Ambiente (CEADES), Barcelona Institute for Global Health, Institute of Parasitology and Biomedicine Lopez Neyra, U.S. Food and Drug Administration (FDA), Drugs for Neglected Diseases, Mundo Sano Foundation, National Institute of Allergy and Infectious Diseases (NIAID) | Trypanosoma Cruzi Infection, Chagas Disease | 05/24 | 05/24 | | |
NCT04274101: Nifurtimox Versus Benznidazole Effectiveness and Tolerance for Chagas Disease Treatment |
|
|
| Active, not recruiting | N/A | 900 | RoW | Clinical Manifestations, Serologic response, Direct method, Adverse events | Hospital de Niños R. Gutierrez de Buenos Aires | Chagas Disease | 08/20 | 02/25 | | |
